🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, claiming the firms concealed safety concerns that the drug created to children's neurological development.

The court filing comes thirty days after President Donald Trump promoted an unverified association between consuming acetaminophen - referred to as paracetamol - throughout gestation and autism spectrum disorder in offspring.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "misled consumers by profiting off of pain and pushing pills ignoring the potential hazards."

Kenvue asserts there is insufficient reliable data linking Tylenol to autism.

"These manufacturers misled for generations, deliberately risking countless individuals to line their pockets," the attorney general, from the Republican party, stated.

The manufacturer commented that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the welfare of American women and children."

On its online platform, the company also mentioned it had "regularly reviewed the pertinent research and there is insufficient valid information that shows a proven link between taking paracetamol and autism spectrum disorder."

Organizations acting on behalf of doctors and health professionals concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in acetaminophen - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can pose major wellness concerns if left untreated.

"In multiple decades of investigation on the use of acetaminophen in pregnancy, no reliable research has successfully concluded that the use of acetaminophen in any trimester of gestation results in neurodevelopmental disorders in offspring," the association stated.

The court filing references recent announcements from the former administration in claiming the medication is potentially dangerous.

Recently, Trump raised alarms from health experts when he advised expectant mothers to "struggle intensely" not to use Tylenol when ill.

The FDA then published an announcement that medical professionals should think about restricting the usage of Tylenol, while also declaring that "a proven link" between the drug and autism spectrum disorder in minors has not been established.

The Health Department head RFK Jr, who supervises the FDA, had vowed in April to undertake "a massive testing and research effort" that would establish the source of autism in a limited time.

But experts cautioned that identifying a sole reason of autism - considered by experts to be the outcome of a intricate combination of inherited and external influences - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and condition that affects how individuals encounter and relate to the world, and is diagnosed using physician assessments.

In his lawsuit, Paxton - aligned with the former president who is running for the Senate - asserts Kenvue and J&J "intentionally overlooked and tried to quiet the research" around acetaminophen and autism.

The lawsuit aims to force the companies "eliminate any commercial messaging" that claims acetaminophen is reliable for pregnant women.

This legal action parallels the complaints of a group of mothers and fathers of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in recently.

The court rejected the legal action, declaring studies from the parents' expert witnesses was inconclusive.